Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma Protein | 7 | 2023 | 673 | 2.620 |
Why?
|
| Chromatin | 5 | 2023 | 2981 | 0.850 |
Why?
|
| E2F Transcription Factors | 4 | 2023 | 270 | 0.610 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 781 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2460 | 0.390 |
Why?
|
| Alternative Splicing | 1 | 2014 | 1105 | 0.310 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 501 | 0.240 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2014 | 168 | 0.240 |
Why?
|
| F-Box Proteins | 3 | 2014 | 201 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8664 | 0.210 |
Why?
|
| E2F1 Transcription Factor | 1 | 2022 | 182 | 0.200 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2022 | 111 | 0.200 |
Why?
|
| Cell Division | 3 | 2023 | 4478 | 0.190 |
Why?
|
| Erythrocytes | 1 | 2010 | 2421 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 321 | 0.180 |
Why?
|
| Cell Cycle | 3 | 2023 | 2937 | 0.180 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 21188 | 0.170 |
Why?
|
| Proteins | 2 | 2014 | 6011 | 0.170 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2024 | 906 | 0.160 |
Why?
|
| Transcription Factors | 6 | 2023 | 12174 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2020 | 8317 | 0.150 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 701 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2022 | 5801 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 354 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2019 | 23653 | 0.130 |
Why?
|
| Cell Cycle Proteins | 3 | 2023 | 3450 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 566 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 2884 | 0.120 |
Why?
|
| Proteomics | 3 | 2019 | 3914 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1120 | 0.110 |
Why?
|
| Genome | 2 | 2023 | 1754 | 0.110 |
Why?
|
| Cell Nucleus | 1 | 2022 | 2885 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11684 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 213 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2019 | 3631 | 0.100 |
Why?
|
| Protein Binding | 3 | 2022 | 9344 | 0.100 |
Why?
|
| Histones | 2 | 2014 | 2603 | 0.090 |
Why?
|
| RNA | 2 | 2014 | 2727 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2014 | 3076 | 0.090 |
Why?
|
| DNA Damage | 1 | 2020 | 2472 | 0.090 |
Why?
|
| Organotin Compounds | 1 | 2010 | 6 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3671 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2018 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2452 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 753 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 2749 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3139 | 0.080 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2011 | 594 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13594 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 17173 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1714 | 0.080 |
Why?
|
| Esters | 1 | 2010 | 212 | 0.080 |
Why?
|
| K562 Cells | 1 | 2010 | 648 | 0.080 |
Why?
|
| Histone Demethylases | 1 | 2011 | 328 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 839 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 7609 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 13427 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1356 | 0.070 |
Why?
|
| DNA Primers | 1 | 2010 | 2827 | 0.060 |
Why?
|
| Animals | 10 | 2023 | 169335 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17629 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 5804 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2014 | 1891 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5342 | 0.060 |
Why?
|
| Arginine | 1 | 2007 | 932 | 0.060 |
Why?
|
| Serine | 1 | 2007 | 831 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 724 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2022 | 6131 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2635 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 859 | 0.050 |
Why?
|
| DNA | 1 | 2016 | 7214 | 0.050 |
Why?
|
| Mitochondria | 1 | 2015 | 3682 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2022 | 108 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2014 | 9618 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 30266 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2022 | 317 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2012 | 2986 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2023 | 859 | 0.040 |
Why?
|
| Cyclins | 1 | 2022 | 606 | 0.040 |
Why?
|
| Mice | 6 | 2020 | 82072 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3608 | 0.040 |
Why?
|
| Superoxides | 1 | 2020 | 389 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 11932 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 12430 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2022 | 664 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11886 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 718 | 0.040 |
Why?
|
| Cell Line | 2 | 2022 | 15604 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 1074 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
| Humans | 14 | 2024 | 768970 | 0.030 |
Why?
|
| Purines | 1 | 2019 | 615 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 580 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2019 | 10486 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3811 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2020 | 3588 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2226 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1351 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22389 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2149 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 808 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 40261 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 3775 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2014 | 444 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3621 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2011 | 109 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2014 | 943 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2012 | 173 | 0.020 |
Why?
|
| Phenotype | 2 | 2022 | 16731 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 996 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 980 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1866 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2010 | 417 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19023 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2009 | 337 | 0.020 |
Why?
|
| Histone Chaperones | 1 | 2009 | 82 | 0.020 |
Why?
|
| Magnesium Chloride | 1 | 2007 | 30 | 0.020 |
Why?
|
| Female | 4 | 2024 | 397515 | 0.020 |
Why?
|
| Interferons | 1 | 2012 | 720 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1408 | 0.020 |
Why?
|
| Colon | 1 | 2015 | 1803 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2010 | 719 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2009 | 488 | 0.020 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 803 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2014 | 1802 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 694 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2942 | 0.020 |
Why?
|
| Virus Replication | 1 | 2014 | 2458 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2835 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 1885 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4290 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2009 | 763 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 1371 | 0.010 |
Why?
|
| Apoptosis | 1 | 2019 | 9527 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2007 | 905 | 0.010 |
Why?
|
| Gene Expression | 1 | 2014 | 7603 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 6512 | 0.010 |
Why?
|
| Cell Movement | 1 | 2011 | 5216 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 30046 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26395 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 10099 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14484 | 0.010 |
Why?
|
| Models, Biological | 1 | 2012 | 9499 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171786 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 223737 | 0.000 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_